[HORIZON EUROPE] Five global health calls launched for collaboration with sub-Saharan Africa within the EDCTP3 partnership.
The European and Developing Countries Clinical Trials Partnership (EDCTP) exists to accelerate the clinical development of new or improved medicinal products for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including (re-)emerging diseases.
In addition, the EDCTP funds activities for research capacity building in Africa, supporting researchers’ careers and strengthening national health research systems.
Current calls open for application:
- HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01: Promoting implementation of research results into policy and practice (RIA – 4M€/project – 9 projects granted)
- HORIZON-JU-GH-EDCTP3-2022-CALL1-01-02: Implementing adaptive platform trials (RIA – 6-8M€/project – 5 projects granted)
- HORIZON-JU-GH-EDCTP3-2022-CALL1-01-03: Genomic epidemiology for surveillance and control of poverty-related and emerging/re-emerging infections in sub-Saharan Africa (RIA – 4M€/project – 4 projects granted)
- HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04: Creating a sustainable clinical trial network for infectious diseases in sub-Saharan Africa (CSA – 1M€/project – 1 project granted)
- HORIZON-JU-GH-EDCTP3-2022-CALL1-01-05: Strengthening regulatory capacity for supporting conduct of clinical trials (CSA – 0.6M€/project – 8 projects granted)
Good to know:
- Consortium composed of at least 3 partners from 3 eligible countries ( of which at least on EU member state or associated country and at least one entity from sub-Saharan Africa associated to EDCTP)
- 100% funding provided (+ 25% overhead)
- Proposal template: standard Horizon Europe template – RIA (45pg) and CSA (30pg)
- Submission deadline: 30 August 2022 at 17h CET
More info on the full programme, budget and eligibility criteria: here or the Fundig and tenders portal
!! Global Health EDCTP3 Joint Undertaking Info Day – 2 June 15h30-17h!!
- Link to event & programme here
Contact the EU-Team for more info and to get support.
May 17, 2022, 10:38 a.m.